fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EAU 2012 Report – Proactive Discussion about BPH

Written by | 6 Nov 2012

It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.

ITS 2012 Report – Difficult donor issues in the time of donor shortages

Written by | 5 Oct 2012

by Maria Dalby – Introduction – In many ways waiting lists to receive an organ transplantation look very much the same today as they did a decade ago… read more.

Cancer risk increased in relatives of patients with serrated polyposis

Written by | 2 Oct 2012

Serrated polyposis is one of the most common polyp syndromes in clinical practice and is often unrecognized during colonoscopy.

Self-referral can increase patients’ travel distance for treatment for prostate cancer

Written by | 28 Sep 2012

Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a… read more.

Obesity promotes prostate cancer by altering gene regulation

Written by | 28 Sep 2012

Prostate cancer is one of the most common cancers in men and early treatment is usually very successful. However, like other cancers, obesity increases the risk of aggressive… read more.

Like prostate cancer, bladder cancer patients may benefit from anti-androgen therapy

Written by | 28 Sep 2012

Bladder cancer patients whose tumors express high levels of the protein CD24 have worse prognoses than patients with lower CD24.

Leading cancer specialists from Europe and beyond recognized at ESMO 2012

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to… read more.

ASCO 2012 Report – Abiraterone added to pre-surgical regimen helps eliminate prostate tumor in some men with high-risk prostate cancer

Written by | 31 Jul 2012

by Bruce Sylvester – In a randomized Phase II study presented at ASCO, investigators reported that 6 months of treatment with the targeted drug abiraterone (Zytiga) when added… read more.

Hormone-depleting drug appears to have efficacy in localized high-risk prostate tumors

Written by | 31 Jul 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – A hormone-depleting drug approved in 2011 for the treatment of metastatic prostate cancer appears to help eliminate… read more.

ESMO 2011 Report – New opportunity for pain control in metastatic carcinoma of the prostate

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – Prostate cancer is one of the leading causes of death due to cancer in men all over the world. Most of the prostate… read more.

ESMO 2011 Report – Radium-223 chloride in bone metastasis

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – Despite encouraging progress in the early diagnosis and better management outcome of common cancers, a high proportion of patients still present with advanced… read more.

More people get cancer, yet fewer die

Written by | 16 Mar 2012

World Health Matters – Australia – by Gary Finnegan – Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.